ArticleBioinformation2024
Validation of endothelin-1 and interleukin-1β as a biomarker for diagnosing peri-implant disorders.
Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endothelin-1 (ET-1) and interleukin-1β (IL-1β) is increased in periodontitis and is linked to inflammatory cytokines among other variables. The purpose of this study was to ascertain if ET-1 and IL-1β are utilized as an early indicator for peri-implant mucositis (PM) and peri-implantitis (PI), as well as to look into the relationship between ET-1 and IL-1β levels and peri-implant illnesses. 58 patients (30 males and 28 females) with a total of 152 implants were included for final analyses. Three groups were formed from the 152 qualifying implants. A plastic probe was used at low pressure of 0.25N to assess the peri-implant parameters like probing pocket depth (PPD), modified gingival index (mGI), BOP being present or absent and modified plaque index (mPI). Mean bone loss (MBL) and the average annual bone loss (ABL) were evaluated. The values were significantly greater in PI group and PM group as compared to healthy subjects. ET-1 and IL-1β levels are significantly increased in peri-implant illnesses. ET-1 and IL-1β may be utilized as diagnostic indicator for peri-implant disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.